Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults — Stella

Recruiting

Back to Prevention of Malaria Transmission and Clinical Malaria trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Mali

University of Science, Technique and Technology of Bamako (Usttb), Bamako

Key details

Phase

Safety & dosing

Sponsor

Serum Institute of India Pvt. Ltd.

Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment target

~1,200 participants

Started

August 2025

Primary completion

November 2027

Age range

9 Years – 50 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov